Class 3 Medicines recall: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s Laboratories (UK) Ltd)
Drug alert number: EL (23)A/03
Date issued: 19 January 2023
The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for:
Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s Laboratories (UK) Ltd), PL 08553/0503
Brief description of the problem
Dr Reddy’s Laboratories (UK) Limited is recalling the batches listed below of Lacidipine 4 mg Film-Coated Tablets as a precautionary measure due to the presence of an unknown solvent-like odour. The tablets are normally odourless. However, in the affected batches, a solvent-like odour is present when the individual blisters are opened. Additionally, some patient complaints have noted that the tablets have an unusual taste. The investigation to determine the root cause and to identify and quantify the odour is ongoing.
The issue is confined to batches B2202043 and B2202044 only. Other batches of Lacidipine 4 mg Film-Coated Tablets marketed by Dr Reddy’s Laboratories (UK) are not affected.
SNOMED Code: 27864411000001103
14 September 2022
14 September 2022
Active Pharmaceutical Ingredients: Lacidipine
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
For medical information enquiries please contact Dr. Reddy’s Laboratories (UK) Ltd Medical Information Department at 01748 828873, or email drreddysGB@EU.ProPharmaGroup.com.
For stock control enquiries please contact Dr. Reddy’s Laboratories (UK) Ltd Customer Services Team at 01482 389858 (or main switchboard at 01482 860228), or email email@example.com.
The post Class 3 Medicines Recall: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s) appeared first on PSNC Website.